Comparing Two Ways to Manage Head and Neck Lymphedema

Description

This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.

Conditions

Head and Neck Cancer, Lymphedema

Talk to us

Study Overview

On this page

Study Details

Study overview

This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.

Comparing Two Ways to Manage Lymphedema in Head and Neck Cancer Survivors

Comparing Two Ways to Manage Head and Neck Lymphedema

Condition
Head and Neck Cancer
Intervention / Treatment

-

Contacts and Locations

Philadelphia

University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Philadelphia

Thomas Jefferson University, Philadelphia, Pennsylvania, United States, 19107

Philadelphia

Temple University Hospital and Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States, 19140

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * \>18 years of age
  • * \<=24 months post-HNC treatment
  • * Diagnosis of head and neck lymphedema and referral by their oncology providers
  • * Able to perform self-manual lymphatic drainage
  • * Having an electronic device (a computer, tablet, iPad, laptop, or smartphone) and internet access at home
  • * Active infection in soft tissues in the head and neck region
  • * History of moderate or severe carotid artery occlusion
  • * Significantly severe lymphedema (e.g., severe periorbital swelling)
  • * Conditions impacting the safe delivery of lymphedema therapy

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Abramson Cancer Center at Penn Medicine,

Study Record Dates

2026-11-30